Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of TB in infants
First trial of a new live attenuated Mycobacterium tuberculosis vaccine in infants.
Results published in The Lancet Respiratory Medicine on 12 August 2019
Comment published in The Lancet Respiratory Medicine on 12 August 2019
Read the full press release here.
Source: TBVI
